APPLICATION
ANDA207329
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-31
LATEST ACTION
2018-05-31
ROUTE
TRANSDERMAL
DOSAGE FORM
GEL
MARKETING STATUS
Discontinued
Products
OXYBUTYNIN CHLORIDEDiscontinued
OXYBUTYNIN CHLORIDE 10% (100MG/PACKET) · GEL · TRANSDERMAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.